ImmuneSensor Therapeutics

ImmuneSensor is currently conducting randomized Phase 2 studies evaluating IMSA101 in combination with radiation and checkpoint inhibitors in patients with solid tumor malignancies.

Autoimmune disease arises when the body's natural defense system cannot distinguish between its own cells and foreign cells

Building a pipeline of novel small molecule and ADC immune stimulating candidates that aim to modulate the innate immune system.

Latest presentations from ImmuneSensor Therapeutics, a clinical-stage biotechnology company focused on developing novel medicines that target the cGAS-STING pathway to modulate the innate immune system.

Latest publications from ImmuneSensor Therapeutics, a clinical-stage biotechnology company focused on developing novel medicines that target the cGAS-STING pathway to modulate the innate immune system.

Latest News from ImmuneSensor Therapeutics, a clinical-stage biotechnology company focused on developing novel medicines that target the cGAS-STING pathway to modulate the innate immune system.

Latest Press Releases from ImmuneSensor Therapeutics, a clinical-stage biotechnology company focused on developing novel medicines that target the cGAS-STING pathway to modulate the innate immune system.

Leveraging the broad versatility of the cGAS-STING pathway to better address treatment challenges and unmet medical needs in autoimmune diseases and cancer.

ImmuneSensor Therapeutics is a clinical-stage biotechnology company led by a team of experienced biotech executives who are committed to creating novel treatments that harness the body's innate immune system to treat a wide range of diseases.

ImmuneSensor Therapeutics, 2110 Research Row, Suite 610, Dallas, TX 75235

ImmuneSensor Therapeutics | Harnessing the innate immune system to treat inflammation, autoimmune disease and cancer

ImmuneSensor collects only personally identifiable information users choose to provide and uses it for legitimate business purposes. It does not sell, share, or otherwise distribute this information to third parties for their purposes.

ImmuneSensor provides information for general informational and educational purposes. Access to and use of the site are subject to its terms and conditions and applicable laws.